Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines
- PMID: 9692547
- DOI: 10.1038/sj.onc.1201881
Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines
Abstract
A novel tumor suppressor gene, PTEN/MMAC1, has been recently shown to be mutated in gliomas, breast, prostate, kidney cancers and melanomas. Loss-of-heterozygosity studies in melanoma have suggested the presence of at least one chromosome 10q locus lost early in tumor progression. In this study, we screened 45 melanoma cell lines and 17 paired uncultured metastatic melanoma and peripheral blood specimens for PTEN/ MMAC1 alterations using PCR-SSCP and direct sequencing. We found nine melanoma cell lines with homozygous deletions (five with intragenic loss) and four cell lines with mutations (one nonsense and one frameshift; two intronic); from among our uncultured melanoma specimens, we found one tumor with a somatic 17 bp duplication in exon 7 leading to a premature stop codon and one tumor with a possible homozygous deletion. Furthermore, we have identified a novel intragenic polymorphism within intron 4 of PTEN/MMAC1. Taken together, these data suggest that PTEN/MMAC1 may be a chromosome 10q tumor suppressor important in melanoma tumor formation or progression.
Similar articles
-
Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies.J Invest Dermatol. 2000 Feb;114(2):277-80. doi: 10.1046/j.1523-1747.2000.00877.x. J Invest Dermatol. 2000. PMID: 10651986
-
Chromosome 10 alterations in prostate adenocarcinoma (review).Oncol Rep. 1998 Nov-Dec;5(6):1329-35. doi: 10.3892/or.5.6.1329. Oncol Rep. 1998. PMID: 9769364 Review.
-
[Involvement of protein tyrosine phosphatases in cancer development].Tanpakushitsu Kakusan Koso. 1998 Jun;43(8 Suppl):1186-92. Tanpakushitsu Kakusan Koso. 1998. PMID: 9655978 Review. Japanese. No abstract available.
-
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.Cancer Res. 1997 Dec 1;57(23):5221-5. Cancer Res. 1997. PMID: 9393738
-
Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.Cancer Res. 1997 Sep 1;57(17):3660-3. Cancer Res. 1997. PMID: 9288767
Cited by
-
p-mTOR, p-ERK and PTEN Expression in Tumor Biopsies and Organoids as Predictive Biomarkers for Patients with HPV Negative Head and Neck Cancer.Head Neck Pathol. 2023 Sep;17(3):697-707. doi: 10.1007/s12105-023-01576-4. Epub 2023 Jul 24. Head Neck Pathol. 2023. PMID: 37486536 Free PMC article.
-
Melanoma: Molecular genetics, metastasis, targeted therapies, immunotherapies, and therapeutic resistance.Genes Dis. 2022 Apr 27;9(6):1608-1623. doi: 10.1016/j.gendis.2022.04.004. eCollection 2022 Nov. Genes Dis. 2022. PMID: 36157497 Free PMC article. Review.
-
Schweinfurthin induces ICD without ER stress and caspase activation.Oncoimmunology. 2022 Aug 3;11(1):2104551. doi: 10.1080/2162402X.2022.2104551. eCollection 2022. Oncoimmunology. 2022. PMID: 35936984 Free PMC article.
-
Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to Immunotherapy.Cancers (Basel). 2021 Oct 28;13(21):5411. doi: 10.3390/cancers13215411. Cancers (Basel). 2021. PMID: 34771574 Free PMC article.
-
Loss of miR-1469 expression mediates melanoma cell migration and invasion.PLoS One. 2021 Sep 1;16(9):e0256629. doi: 10.1371/journal.pone.0256629. eCollection 2021. PLoS One. 2021. PMID: 34469478 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
